SCDM Clinical Trial Operations 2 — Questions and Answers
Question 1: What is a 'clinical study report' (CSR) in clinical trial operations?
- A comprehensive document describing the study design, conduct, results, and conclusions for regulatory submission (Correct answer)
- A monthly site performance report submitted to the sponsor
- A safety report submitted to the IRB after each SAE
- An interim analysis summary shared with the DSMB
Correct answer: A comprehensive document describing the study design, conduct, results, and conclusions for regulatory submission
A CSR is a structured document (per ICH E3 guidance) that comprehensively describes the trial's design, methods, conduct, efficacy, and safety results for regulatory submission.
Question 2: What is a 'co-monitoring' visit in clinical trials?
- A monitoring visit attended by both the site monitor and a QA representative to assess monitoring quality and compliance (Correct answer)
- A joint visit by two monitors from different CROs to the same site
- A visit where the site investigator monitors their own data quality
- A visit conducted simultaneously at two different sites on the same day
Correct answer: A monitoring visit attended by both the site monitor and a QA representative to assess monitoring quality and compliance
Co-monitoring involves a QA auditor accompanying the site monitor to evaluate monitoring quality, GCP compliance, and the overall effectiveness of the monitoring program.
Question 3: What is a 'protocol synopsis' used for in clinical trial operations?
- A concise summary of the full protocol describing study objectives, design, population, and key endpoints for review (Correct answer)
- A one-page overview submitted to insurance companies for coverage authorization
- A simplified version of the protocol translated for lay subject reading
- A brief protocol summary provided to site staff for daily reference
Correct answer: A concise summary of the full protocol describing study objectives, design, population, and key endpoints for review
A protocol synopsis is a structured summary of the full protocol used for rapid review by ethics committees, investigators, and regulatory authorities during study planning and submission.
Question 4: What is 'site close-out' in clinical trial operations?
- The formal process of ending a site's participation, including final data review, IP reconciliation, and document archiving (Correct answer)
- The process of withdrawing a site from the trial due to poor performance
- A regulatory agency inspection conducted at study end
- The decommissioning of the EDC system after database lock
Correct answer: The formal process of ending a site's participation, including final data review, IP reconciliation, and document archiving
Site close-out involves a final monitoring visit to confirm all data are complete and clean, investigational product is reconciled, essential documents are archived, and the site is formally closed.
Question 5: What is a 'blinded safety review' in clinical trial operations?
- A periodic review of accumulating safety data without treatment assignment information to assess overall safety signals (Correct answer)
- A review of adverse events conducted without subject identity information
- An evaluation of site safety procedures without notifying site staff
- A review of laboratory safety values by a blinded statistician only
Correct answer: A periodic review of accumulating safety data without treatment assignment information to assess overall safety signals
A blinded safety review examines aggregate safety data while treatment codes remain blinded, allowing safety assessment without breaking the study blind or introducing analysis bias.
Question 6: What is the function of a 'feasibility assessment' before site selection in clinical trials?
- To evaluate a site's patient population, infrastructure, staff experience, and capacity to conduct the trial per protocol (Correct answer)
- To estimate the total cost of the trial before sponsor approval
- To assess the regulatory environment in the country where the site is located
- To review the investigator's publication record for relevant therapeutic area experience
Correct answer: To evaluate a site's patient population, infrastructure, staff experience, and capacity to conduct the trial per protocol
A feasibility assessment evaluates prospective sites on patient availability, facilities, staff qualifications, competing trials, and regulatory environment to select optimal sites for successful trial conduct.
SCDM Clinical Trial Operations 2
What is a 'clinical study report' (CSR) in clinical trial operations?